Published in Circulation on September 19, 2011
Circadian dependence of infarct size and left ventricular function after ST elevation myocardial infarction. Circ Res (2011) 5.87
Door-to-balloon: where do we lose time? Single centre experience in India. Indian Heart J (2012) 1.10
The influence of residential distance on time to treatment in ST-elevation myocardial infarction patients. Neth Heart J (2014) 0.96
Macroergonomics in Healthcare Quality and Patient Safety. Rev Hum Factors Ergon (2013) 0.89
Timeliness of interfacility transfer for ED patients with ST-elevation myocardial infarction. Am J Emerg Med (2015) 0.85
Interhospital transfer due to failed prehospital diagnosis for primary percutaneous coronary intervention: an observational study on incidence, predictors, and clinical impact. Eur Heart J Acute Cardiovasc Care (2013) 0.84
Transport time and care processes for patients transferred with ST-segment-elevation myocardial infarction: the reperfusion in acute myocardial infarction in Carolina emergency rooms experience. Circ Cardiovasc Interv (2012) 0.81
Utilizations and Perceptions of Emergency Medical Services by Patients with ST-Segments Elevation Acute Myocardial Infarction in Abu Dhabi: A Multicenter Study. Heart Views (2016) 0.81
Impact of TIMI 3 patency before primary percutaneous coronary intervention for ST-elevation myocardial infarction on clinical outcome: results from the ASSENT-4 PCI study. Eur Heart J Acute Cardiovasc Care (2012) 0.78
Exploring the treatment delay in the care of patients with ST-elevation myocardial infarction undergoing acute percutaneous coronary intervention: a cross-sectional study. BMC Health Serv Res (2015) 0.75
Physician perceptions and recommendations about pre-hospital emergency medical services for patients with ST-elevation acute myocardial infarction in Abu Dhabi. J Saudi Heart Assoc (2015) 0.75
System dynamics modeling in the evaluation of delays of care in ST-segment elevation myocardial infarction patients within a tiered health system. PLoS One (2014) 0.75
Association Between Hospital Practices and Door-in-door-out Time in ST-segment Elevation Myocardial Infarction. Crit Pathw Cardiol (2016) 0.75
Association of Emergency Department Length of Stay and Crowding for Patients with ST-Elevation Myocardial Infarction. West J Emerg Med (2015) 0.75
Causes of delay in door-to-balloon time in south-east Asian patients undergoing primary percutaneous coronary intervention. PLoS One (2017) 0.75
Statin Eligibility and Outpatient Care Prior to ST-Segment Elevation Myocardial Infarction. J Am Heart Assoc (2017) 0.75
Unmet goals in the treatment of Acute Myocardial Infarction: Review. F1000Res (2017) 0.75
A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol (2009) 8.13
Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ (2011) 6.80
The association of registered nurse staffing levels and patient outcomes: systematic review and meta-analysis. Med Care (2007) 6.09
Circadian dependence of infarct size and left ventricular function after ST elevation myocardial infarction. Circ Res (2011) 5.87
Efficacy of a device to narrow the coronary sinus in refractory angina. N Engl J Med (2015) 5.36
An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. J Cancer Surviv (2010) 4.73
Predicting nursing home admission in the U.S: a meta-analysis. BMC Geriatr (2007) 4.52
Comparison of body mass index, waist circumference, and waist/hip ratio in predicting incident diabetes: a meta-analysis. Epidemiol Rev (2007) 4.43
Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study. Lancet (2013) 3.74
Intramyocardial, autologous CD34+ cell therapy for refractory angina. Circ Res (2011) 3.72
Controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev (2005) 3.34
A regional system to provide timely access to percutaneous coronary intervention for ST-elevation myocardial infarction. Circulation (2007) 3.26
Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study. Lancet (2013) 3.17
"False-positive" cardiac catheterization laboratory activation among patients with suspected ST-segment elevation myocardial infarction. JAMA (2007) 2.89
Patients with coronary artery disease not amenable to traditional revascularization: prevalence and 3-year mortality. Catheter Cardiovasc Interv (2010) 2.88
Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial. Circulation (2007) 2.88
Myocardial injury and long-term mortality following moderate to severe carbon monoxide poisoning. JAMA (2006) 2.83
ST-elevation myocardial infarction diagnosed after hospital admission. Circulation (2014) 2.83
Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia. Circulation (2008) 2.82
Comparison of circadian rhythm patterns in Tako-tsubo cardiomyopathy versus ST-segment elevation myocardial infarction. Am J Cardiol (2012) 2.66
Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction. J Am Coll Cardiol (2003) 2.52
Gender disparity in cardiac procedures and medication use for acute myocardial infarction. Am Heart J (2008) 2.44
Cardiovascular manifestations of moderate to severe carbon monoxide poisoning. J Am Coll Cardiol (2005) 2.19
Just what the doctor ordered. Review of the evidence of the impact of computerized physician order entry system on medication errors. Health Serv Res (2008) 2.05
Procedural variation in the performance of primary percutaneous coronary intervention for ST-elevation myocardial infarction: a SCAI-based survey study of US interventional cardiologists. Catheter Cardiovasc Interv (2013) 2.02
Benefit of transferring ST-segment-elevation myocardial infarction patients for percutaneous coronary intervention compared with administration of onsite fibrinolytic declines as delays increase. Circulation (2011) 1.95
Development of a network to test strategies in cardiovascular cell delivery: the NHLBI-sponsored Cardiovascular Cell Therapy Research Network (CCTRN). J Cardiovasc Transl Res (2010) 1.84
Recommendations for successful training on methods of delivery of biologics for cardiac regeneration: a report of the International Society for Cardiovascular Translational Research. JACC Cardiovasc Interv (2010) 1.74
Long-term survival in patients with refractory angina. Eur Heart J (2013) 1.68
Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy. J Am Coll Cardiol (2013) 1.65
Smoking and incidence of atrial fibrillation: results from the Atherosclerosis Risk in Communities (ARIC) study. Heart Rhythm (2011) 1.64
A target-mediated model to describe the pharmacokinetics and hemodynamic effects of recombinant human vascular endothelial growth factor in humans. Clin Pharmacol Ther (2002) 1.63
Relationship between intravascular ultrasound guidance and clinical outcomes after drug-eluting stents: the assessment of dual antiplatelet therapy with drug-eluting stents (ADAPT-DES) study. Circulation (2013) 1.62
Increased prevalence of coronary artery aneurysms among cocaine users. Circulation (2005) 1.60
Effectiveness of a smoking cessation program for peripheral artery disease patients: a randomized controlled trial. J Am Coll Cardiol (2010) 1.59
LateTIME: a phase-II, randomized, double-blinded, placebo-controlled, pilot trial evaluating the safety and effect of administration of bone marrow mononuclear cells 2 to 3 weeks after acute myocardial infarction. Tex Heart Inst J (2010) 1.52
Safety and efficacy of a pharmaco-invasive reperfusion strategy in rural ST-elevation myocardial infarction patients with expected delays due to long-distance transfers. Eur Heart J (2011) 1.46
Elevated T-wave alternans predicts nonsustained ventricular tachycardia in association with percutaneous coronary intervention in ST-segment elevation myocardial infarction (STEMI) patients. J Cardiovasc Electrophysiol (2013) 1.46
The prognostic role of mitral regurgitation after primary percutaneous coronary intervention for acute ST-elevation myocardial infarction. Catheter Cardiovasc Interv (2012) 1.45
Increasing survival rate from commotio cordis. Heart Rhythm (2012) 1.45
Long-term follow-up of older patients with Mobitz type I second degree atrioventricular block. Heart (2012) 1.44
Omega-3 fatty acids and incident type 2 diabetes: the Singapore Chinese Health Study. Am J Clin Nutr (2011) 1.44
New generation drug-eluting stents for ST-elevation myocardial infarction: a new paradigm for safety. Catheter Cardiovasc Interv (2014) 1.44
Fifteen-year trends in cardiovascular risk factors (1980-1982 through 1995-1997): the Minnesota Heart Survey. Am J Epidemiol (2002) 1.43
Emerging therapies for refractory angina. Minn Med (2008) 1.42
How accurate is the eyeball test?: a comparison of physician's subjective assessment versus statistical methods in estimating mortality risk after cardiac surgery. Circ Cardiovasc Qual Outcomes (2014) 1.41
Vascular hospitalization rates and costs in patients with peripheral artery disease in the United States. Circ Cardiovasc Qual Outcomes (2010) 1.39
Systems of care for ST-segment-elevation myocardial infarction: a report From the American Heart Association's Mission: Lifeline. Circ Cardiovasc Qual Outcomes (2012) 1.39
Phase I cardiovascular cell therapy clinical trials: Are we running with scissors? Am Heart J (2008) 1.39
Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data. Circ Res (2015) 1.39
A randomized study of transendocardial injection of autologous bone marrow mononuclear cells and cell function analysis in ischemic heart failure (FOCUS-HF). Am Heart J (2011) 1.35
Standardized reporting guidelines for studies evaluating risk stratification of emergency department patients with potential acute coronary syndromes. Ann Emerg Med (2004) 1.33
BMI, all-cause and cause-specific mortality in Chinese Singaporean men and women: the Singapore Chinese health study. PLoS One (2010) 1.32
Pathophysiology of coronary artery restenosis. Rev Cardiovasc Med (2002) 1.31
Nurse staffing and quality of patient care. Evid Rep Technol Assess (Full Rep) (2007) 1.30
Weight loss and proteinuria: systematic review of clinical trials and comparative cohorts. Nephrol Dial Transplant (2009) 1.28
Cellular therapy with Ixmyelocel-T to treat critical limb ischemia: the randomized, double-blind, placebo-controlled RESTORE-CLI trial. Mol Ther (2012) 1.27
Extracellular proteases in atherosclerosis and restenosis. Arterioscler Thromb Vasc Biol (2005) 1.27
Results of a phase 1, randomized, double-blind, placebo-controlled trial of bone marrow mononuclear stem cell administration in patients following ST-elevation myocardial infarction. Am Heart J (2010) 1.27
Effect of hypoxia-inducible factor-1alpha gene therapy on walking performance in patients with intermittent claudication. Circulation (2011) 1.25
ST-segment elevation myocardial infarction: recommendations on triage of patients to heart attack centers: is it time for a national policy for the treatment of ST-segment elevation myocardial infarction? J Am Coll Cardiol (2006) 1.24
Dietary patterns and incident type 2 diabetes in chinese men and women: the singapore chinese health study. Diabetes Care (2011) 1.21
Hospitalized heart failure: rates and long-term mortality. J Card Fail (2004) 1.19
A call to action: women and peripheral artery disease: a scientific statement from the American Heart Association. Circulation (2012) 1.19
Growth in percutaneous coronary intervention capacity relative to population and disease prevalence. J Am Heart Assoc (2013) 1.16
The global pandemic of peripheral artery disease. Lancet (2013) 1.15
Therapeutic hypothermia after out-of-hospital cardiac arrest: evaluation of a regional system to increase access to cooling. Circulation (2011) 1.14
Microemboli and microvascular obstruction in acute coronary thrombosis and sudden coronary death: relation to epicardial plaque histopathology. J Am Coll Cardiol (2009) 1.14
Developing mechanistic insights into cardiovascular cell therapy: Cardiovascular Cell Therapy Research Network Biorepository Core Laboratory rationale. Am Heart J (2011) 1.13
Bone marrow mononuclear cell therapy for acute myocardial infarction: a perspective from the cardiovascular cell therapy research network. Circ Res (2014) 1.12
Long-term follow-up of patients undergoing postconditioning during ST-elevation myocardial infarction. J Cardiovasc Transl Res (2010) 1.10
Musculoskeletal pain in obese children and adolescents. Acta Paediatr (2008) 1.09
The association between atopy and childhood/adolescent leukemia: a meta-analysis. Am J Epidemiol (2010) 1.09
Comprehensive review of procedures for total colonic aganglionosis. J Pediatr Surg (2009) 1.07
The incidence and health economic burden of ischemic amputation in Minnesota, 2005-2008. Prev Chronic Dis (2011) 1.07
Results from a phase II multicenter, double-blind placebo-controlled study of Del-1 (VLTS-589) for intermittent claudication in subjects with peripheral arterial disease. Am Heart J (2007) 1.05
A report of quality improvement in the care of patients with acute coronary syndromes. Crit Pathw Cardiol (2011) 1.04
Standardized reporting guidelines for studies evaluating risk stratification of ED patients with potential acute coronary syndromes. Acad Emerg Med (2004) 1.04
Design of a standardized system for transfer of patients with ST-elevation myocardial infarction for percutaneous coronary intervention. Am Heart J (2005) 1.03
Multidisciplinary standardized care for acute aortic dissection: design and initial outcomes of a regional care model. Circ Cardiovasc Qual Outcomes (2010) 1.03
Evaluation and management of the patient who has cocaine-associated chest pain. Cardiol Clin (2006) 1.02